Deepen Your Knowledge
Resources & Trials
Further Learning
The studies referenced are shared for educational purposes and should not be interpreted as medical recommendations or definitive prevention strategies. Individual outcomes may vary, and readers should seek guidance from qualified healthcare providers before making health decisions.
Trials and Studies of Interest
Click on each study below to learn about ongoing trials and observational studies, and to explore opportunities to join studies that are actively recruiting participants.
Trontier Program
Studies testing a new antibody treatment designed to help clear amyloid from the brain in people with early Alzheimer’s disease that may have fewer side effects than existing treatments.
Traveller
A program designed to find people who may qualify for future and ongoing studies of Trontinemab.
Ahead 3-45
A prevention study using a medication already approved for symptomatic Alzheimer’s disease to see if it can slow or stop Alzheimer’s before symptoms begin.
Trailblazer-ALZ 3
A prevention trial testing whether the antibody Donanemab, a medication currently approved for persons with symptomatic Alzheimer’s disease, can help delay or prevent the earliest stages of Alzheimer’s disease.
NIA Registry on Alzheimer’s Trials
A national directory of 495 currently active Alzheimer’s research studies looking for participants via the National Institute on Aging.